New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis

Clinica Chimica Acta

Volumn 412, Issue 17-18, 2011, Pages 1662-1667

  Basso, Daniela ^a   Guariso, Graziella ^a   Bozzato, Dania ^a   Rossi, Elisa ^a   Pescarin, Matilde ^a   Fogar, Paola ^a   Moz, Stefania ^a   Navaglia, Filippo ^a   Pelloso, Michela ^a   Gasparetto, Marco ^a   Zambon, Carlo Federico ^a   Padoan, Andrea ^a   Greco, Eliana ^a   Rugge, Massimo ^a   Plebani, Mario ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Celiac disease; Children; Deamidated gliadin peptides; Neo epitopes; Transglutaminase

Indexed keywords

GLIADIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; CASE-CONTROL STUDIES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TRANSGLUTAMINASES;

EID: 79959296572     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.05.024     Document Type: Article

References (40)

1. Green P.H., Cellier C. Celiac disease. N Engl J Med 2007, 357:1731-1743.
2. Mustalahti K., Catassi C., Reunanen A., et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med 2010, 42:587-595.
3. Barton S.H., Kelly D.G., Murray J.A. Nutritional deficiencies in celiac disease. Gastroenterol Clin North Am 2007, 36:93-108.
4. Fasano A., Catassi C. Coeliac disease in children. Best Pract Res Clin Gastroenterol 2005, 19:467-478.
5. Tack G.J., Verbeek W.H., Schreurs M.W., Mulder C.J. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol 2010, 7:204-213.
6. NIH Consensus Development Conference on Celiac Disease. NIH Consens State Sci Statements 2004, 21(1):1-23.
7. Hill I.D., Dirks M.H., Liptak G.S., et al. Guidelines for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005, 40:1-19.
8. Institute A.G.A. AGA institute medical position statement on the diagnosis and management of celiac disease. Gastroenterology 2006, 131:1977-1980.
9. Zintzaras E., Germenis A.E. Performance of antibodies against tissue transglutaminase for the diagnosis of celiac disease: meta-analysis. Clin Vaccine Immunol 2006, 13:187-192.
10. Lewis N.R., Scott B.B. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2010, 31:73-81.
11. Devendra D., Uduku C., Liu E., Wilson Y. Discrepancies between histology and serology for the diagnosis of coeliac disease (1) [Letter]. Clin Med 2010, 10:98.
12. Dieterich W., Ehnis T., Bauer M., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997, 3:797-801.
13. Basso D., Guariso G., Fasolo M., et al. A new indirect chemiluminescent immunoassay to measure anti-tissue transglutaminase antibodies. J Pediatr Gastroenterol Nutr 2006, 43:613-618.
14. Basso D., Guariso G., Fogar P., Navaglia F., Zambon C.F., Plebani M. Insights in the laboratory diagnosis of celiac disease. Lupus 2006, 15:462-465.
15. Koning F., Schuppan D., Cerf-Bensussan N., Sollid L.M. Pathomechanisms in celiac disease. Best Pract Res Clin Gastroenterol 2005, 19:373-387.
16. Schuppan D., Junker Y., Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009, 137:1912-1933.
17. Schwertz E., Kahlenberg F., Sack U., et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem 2004, 50:2370-2375.
18. Sugai E., Vázquez H., Nachman F., et al. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Clin Gastroenterol Hepatol 2006, 4:1112-1117.
19. Agardh D. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Clin Gastroenterol Hepatol 2007, 5:1276-1281.
20. Niveloni S., Sugai E., Cabanne A., et al. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease. Clin Chem 2007, 53:2186-2192.
21. Korponay-Szabó I.R., Vecsei Z., Király R., et al. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize. J Pediatr Gastroenterol Nutr 2008, 46:253-261.
22. Basso D., Guariso G., Fogar P., et al. Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin Chem 2009, 55:150-157.
23. Fasano A., Araya M., Bhatnagar S., et al. Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition consensus report on celiac disease. J Pediatr Gastroenterol Nutr 2008, 47:214-219.
24. Villalta D., Tonutti E., Prause C., et al. IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency. Clin Chem 2010, 56:464-468.
25. Hill P.G., Holmes G.K. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 2008, 27:572-577.
26. Catassi C., Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med 2010, 123:691-693.
27. Ciccocioppo R., Di Sabatino A., Ara C., et al. Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa. Clin Exp Immunol 2003, 134:516-524.
28. Fleckenstein B., Qiao S.W., Larsen M.R., Jung G., Roepstorff P., Sollid L.M. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem 2004, 279:17607-17616.
29. Matthias T., Neidhöfer S., Pfeiffer S., Prager K., Reuter S., Gershwin M.E. Novel trends in celiac disease. Cell Mol Immunol 2011, 8:121-125.
30. Oberhuber G. Histopathology of celiac disease. Biomed Pharmacother 2000, 54:368-372.
31. van der Windt D.A., Jellema P., Mulder C.J., Kneepkens C.M., van der Horst H.E. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA 2010, 303:1738-1746.
32. Plebani M., Basso D. Diagnostic testing for celiac disease [Letter]. JAMA. 2010, 304:639.
33. Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol 2001, 21:303-309.
34. Corazza G.R., Villanacci V. Coeliac disease. J Clin Pathol 2005, 58:573-574.
35. Villanacci V., Ceppa P., Tavani E., et al. Coeliac disease: the histology report. Dig Liver Dis 2011, 43(Suppl 4):S385-S395.
36. Lagerqvist C., Dahlbom I., Hansson T., et al. Antigliadin immunoglobulin A best in finding celiac disease in children younger than 18months of age. J Pediatr Gastroenterol Nutr 2008, 47:428-435.
37. Parizade M., Shainberg B. Positive deamidated gliadin peptide antibodies and negative tissue transglutaminase IgA antibodies in a pediatric population: to biopsy or not to biopsy. Clin Vaccine Immunol 2010, 17:884-886.
38. Liu E., Li M., Emery L., et al. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Pediatr Gastroenterol Nutr 2007, 45:293-300.
39. Walker M.M., Murray J.A., Ronkainen J., et al. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology 2010, 139:112-119.
40. Basso D., Guariso G., Plebani M. Serologic testing for celiac disease [Letter]. Clin Chem 2002, 48:2082-2083.